Sign in
4/A

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-23-048441

Director bought 700,000 shares at $20.00 ($14,000,000)

  • Director acquired 2,032,501 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
William Arsani Director 2021-03-30 Conversion +1,217,627 1,217,627 I
William Arsani Director 2021-03-30 Conversion +814,874 814,874 I
William Arsani Director 2021-03-30 Purchase +700,000 $20.00 $14,000,000 700,000 I
Open-market purchases · 700,000 sh · avg $20.00 · $14,000,000
Loading xslF345X05/doc4a.xml…